BMP‑2 and miR‑29c in osteosarcoma tissues on proliferation and invasion of osteosarcoma cells

Expression of bone morphogenetic protein (BMP)‑2 and microRNA (miR)‑29c in osteosarcoma tissues and effects on proliferation and invasion of osteosarcoma cells were investigated. A retrospective analysis of 75 patients with osteosarcoma who underwent surgery in Tianjin Baodi Hospital from May 2013 to June 2017 was conducted. A total of 75 osteosarcoma tissues and 51 normal paraneoplastic tissues were collected. RT‑PCR was used to compare the expression difference of BMP‑2 and miR‑29c. miR‑29c mimics (experimental group A) and BMP‑2 siRNA plasmid (experimental group B) were transfected into human osteosarcoma cells MG‑63, respectively. The transfected cells were divided into miRNA negative control (miR‑NC) group (cells transfected with miR‑negative control), siRNA negative control group (cells transfected with non‑silent siRNA) and blank group (cells without any transfection). MTT assay was used to detect cell proliferation in each group at different time periods. Transwell insert was used to detect invasion of cells in vitro. The relative expression of BMP‑2 in osteosarcoma tissue was significantly higher than that in paraneoplastic tissue (P<0.05). Τhe relative expression of miR‑29c in osteosarcoma tissue was significantly lower than that in paraneoplastic tissue (P<0.05). The cell survival rates in experimental groups A and B were significantly lower than those in the blank, miR‑NC negative control and siRNA negative control groups on day 5 (P<0.05). The number of cell transmembranes in experimental groups A and B was significantly lower than those in the blank, miR‑NC negative control and siRNA negative control groups (P<0.05). BMP‑2 is over‑expressed in osteosarcoma tissues, and miR‑29c is under‑expressed in osteosarcoma tissues. Interfering with the expression of BMP‑2 and overexpression of miR‑29c can inhibit the proliferation and invasion of osteosarcoma cells, indicating that BMP‑2 and miR‑29c may be involved in the regulation of proliferation and metastasis of osteosarcoma cells and could be used as new molecular target markers for the diagnosis and treatment of osteosarcoma.